<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04325230</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2020/01</org_study_id>
    <nct_id>NCT04325230</nct_id>
  </id_info>
  <brief_title>Prognostic Value of Arterial Spin Labeling Brain Perfusion MRI in Term Neonates With Hypoxic-ischemic Encephalopathy</brief_title>
  <acronym>BBASL</acronym>
  <official_title>Prognostic Value of Arterial Spin Labeling Brain Perfusion MRI in Term Neonates With Hypoxic-ischemic Encephalopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study will be to evaluate the prognostic value at 3 months of life
      of brain perfusion MRI determined by Arterial Spin Labeling technique in the first week of
      life of term newborns with hypoxic-ischemic encephalopathy requiring management in neonatal
      intensive care unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypoxic-ischemic encephalopathy is the result of birth asphyxia due to transitory cerebral
      blood flow drop during perinatal period. It is the leading cause of neonatal encephalopathy,
      and thus a major cause of perinatal mortality, morbidity and adverse neurodevelopmental
      outcome. Usual care brain MRI is critically important in the diagnosis and prognosis. Lasting
      about 30 to 40 minutes, MRI exam includes successive sequences providing complementary
      information but none relatively to brain perfusion. Perfusion MRI without contrast media
      injection is possible using Arterial Spin Labeling (ASL) sequence. ASL is highly suitable for
      neonates, noninvasiveness, and lasts only 5 minutes. However, only one study assessed ASL as
      a prognostic factor. The purpose of the study is therefore to perform ASL sequence within
      usual care brain MRI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 17, 2020</start_date>
  <completion_date type="Anticipated">July 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical outcome</measure>
    <time_frame>3 months of life (Month 3)</time_frame>
    <description>judged as favorable, or as adverse in case of death or cerebral palsy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome</measure>
    <time_frame>Month 6, Month 12</time_frame>
    <description>judged as favorable or as adverse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic performances of ASL</measure>
    <time_frame>Baseline</time_frame>
    <description>Prognostic performances of ASL in comparison with routinely used MRI parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of ASL sequences</measure>
    <time_frame>Baseline</time_frame>
    <description>according to visual analysis of artifacts and number of negative voxels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inter-observer agreement of the interpretation of the perfusion data</measure>
    <time_frame>Baseline</time_frame>
    <description>Intra Class correlation coefficient</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Neonatal Hypoxic Ischemic Encephalopathy</condition>
  <arm_group>
    <arm_group_label>Arterial Spin Labeling sequence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ASL sequence added to the usual care brain MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arterial Spin Labeling sequence</intervention_name>
    <description>ASL sequence added to the usual care brain MRI</description>
    <arm_group_label>Arterial Spin Labeling sequence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  neonates with a term ≥ 36 weeks of amenorrhea and birth weight ≥ 1800 g.

          -  presenting with perinatal asphyxia defined as combination of:

               -  an acute perinatal event (such as placental abruption, cord prolapse, and/or
                  severe foetal heart rate abnormalities);

               -  and at least one of the following criteria:

                    -  Apgar score ≤ 5 at 10 minutes of life,

                    -  mask ventilation or intubation at 10 minutes of life,

                    -  metabolic acidosis defined as pH &lt; 7 or base deficit ≥ 16 mmol/L or lactates
                       ≥ 11 mmol/L within the first 60 minutes of life on cord or other arterial
                       venous or capillary blood sample.

          -  patient treated or not with therapeutic hypothermia for 72 hours.

          -  affiliated patient or beneficiary of a social security scheme.

          -  informed and signed parental consent.

        Exclusion Criteria:

          -  perinatal arterial ischemic stroke.

          -  congenital neuro-metabolic disorder.

          -  severe malformative abnormalities.

          -  MRI contra-indication.

          -  Poor understanding of the holders of parental authority
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>8 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Chateil, MD, PhD</last_name>
    <phone>+33556795950</phone>
    <email>jean-francois.chateil@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean Delmas</last_name>
    <email>jean.delmas@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-François Chateil, MD, PhD</last_name>
      <email>jean-francois.chateil@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Jean Delmas</last_name>
      <email>jean.delmas@chu-bordeaux.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 16, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2020</study_first_posted>
  <last_update_submitted>May 30, 2020</last_update_submitted>
  <last_update_submitted_qc>May 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypoxic-ischemic encephalopathy</keyword>
  <keyword>Neonate</keyword>
  <keyword>Perfusion</keyword>
  <keyword>MRI</keyword>
  <keyword>Arterial Spin Labeling</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

